Congress on Safety Assessment of Nanomaterials to be Held at Bizkaia Technology Park

The IK4-GAIKER technological centre, along with the IVTIP European Platform (In Vitro Testing Industrial Platform) is organizing a congress on the 19th April on the "Safety Assessment of Nanomaterials: Current Status and Challenges Ahead".

International Experts Debate on the Safety of Nanomaterials in the Basque Country.

The event, which will be held at the centre's headquarters at the of the Bizkaia Technology Park, will aim at delving deeper into the advances of nanotoxicology as a new toxicology discipline and will count on experts from all around the globe who will present the latest advancements as well as future challenges in this field.

Nanomaterials have new physical properties which can improve the performance of the materials they are incorporated with. Nevertheless, materials at a nanometric scale can also present toxicological characteristics which are different from the same substances at conventional scales which can pose a risk to human health and the environment.

The congress will deal with aspects related with the quality of the current studies in nanotoxicology, with special emphasis on chapters related with the validation of in vitro tests versus in vivo, and will debate the new in vitro models of the physiological barriers which will allow for the evaluation of the safety and efficiency of the nanomaterials.

The IVTIP brings together research centres like Fraunhofer and TNO and companies from the cosmetics, pharmaceutical and chemical industries like L'Oreal, Henkel, Novo Nordisk and Philip Morris, among others. This platform works on the search for in vitro systems which allow for a safe evaluation of new compounds and substitutes trials with animals to avoid their use and sacrifice.

Source: nanoBasque

Tell Us What You Think

Do you have a review, update or anything you would like to add to this news story?

Leave your feedback
Your comment type

While we only use edited and approved content for Azthena answers, it may on occasions provide incorrect responses. Please confirm any data provided with the related suppliers or authors. We do not provide medical advice, if you search for medical information you must always consult a medical professional before acting on any information provided.

Your questions, but not your email details will be shared with OpenAI and retained for 30 days in accordance with their privacy principles.

Please do not ask questions that use sensitive or confidential information.

Read the full Terms & Conditions.